title: Time- and dose-dependent neuroprotective effects of sex steroid hormones on inflammatory cytokines after a traumatic brain injury.
abstract: Following a traumatic brain injury (TBI), excessive release of proinflammatory cytokines is the major cause of cerebral edema and neuronal loss. This study was designed to examine changes in concentrations of some proinflammatory cytokines-including interleukin-1 beta (IL-1β), interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-α), and transforming growth factor-beta (TGF-β)-in a rat model of TBI in which the animals were treated with different doses of estrogen or progesterone 6 and 24 h after the TBI. Adult female rats were divided into 14 groups. Hormones or vehicle were given intraperitoneally 30 min after a moderate TBI was induced by the Marmarou method. The levels of proinflammatory cytokines in brain were measured at 6 and 24 h after the TBI. A high dose of estrogen (E2) or a low dose of progesterone (P1) increased brain levels of IL-1β 52.7% and 79.2% respectively at 6 h after the TBI. By 24h, IL-1β levels in the brain were 27.5% and 27% lower following administration of estrogen low dose (E1) or E2, respectively. High-dose administration of progesterone reduced brain levels of IL-6 to 45.9% at 6 h after the TBI, and P1 and E1 treatment significantly decreased IL-6 levels at 24 h. Brain levels of TNF-α were 72.5% lower at 6 h after the TBI following P2 treatment and 48.5% higher at 24 hrs following treatment with E2. The levels of TGF-β were also 3.37 times higher 24 h after the TBI following treatment with E1. Both doses of the hormones tested increases TGF-β levels 6 h after the TBI. Based on our findings, we conclude that progesterone and estrogen influence the levels of proinflammatory cytokines either at the primary or secondary stages after a TBI. Accordingly, this study suggests a mechanism by which hormones reduce cerebral edema.
authors.affiliation: Physiology Research Center, Ahwaz University of Medical Sciences, Ahwaz, Iran.
authors.forename: Ali Reza
authors.initials: AR
authors.lastname: Sarkaki
authors.forename: Mohammad
authors.initials: M
authors.lastname: Khaksari Haddad
authors.forename: Zahra
authors.initials: Z
authors.lastname: Soltani
authors.forename: Nader
authors.initials: N
authors.lastname: Shahrokhi
authors.forename: Mehdi
authors.initials: M
authors.lastname: Mahmoodi
mesh_terms: D000818:Animals; D001930:Brain Injuries / Q000188:drug therapy / Q000378:metabolism; D016207:Cytokines / Q000096:biosynthesis / Q000378:metabolism* / Q000502:physiology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004967:Estrogens / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D018836:Inflammation Mediators / Q000378:metabolism* / Q000502:physiology; D018696:Neuroprotective Agents / Q000494:pharmacology; D011374:Progesterone / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D013997:Time Factors
chemical_list: D016207:Cytokines; D004967:Estrogens; D018836:Inflammation Mediators; D018696:Neuroprotective Agents; D011374:Progesterone